VERA — Vera Therapeutics, Balance Sheet
0.000.00%
Annual balance sheet for Vera Therapeutics,, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 79.7 | 115 | 161 | 641 | 715 |
| Net Total Receivables | — | — | — | 3.77 | 3.29 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 82.5 | 126 | 172 | 651 | 729 |
| Net Property, Plant And Equipment | — | 5.22 | 3.04 | 4.33 | 3.3 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 83.7 | 131 | 176 | 656 | 735 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7.69 | 25.6 | 22.3 | 25.4 | 53.5 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 14.2 | 54.5 | 73.9 | 78.5 | 130 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 69.6 | 76.9 | 102 | 577 | 605 |
| Total Liabilities & Shareholders' Equity | 83.7 | 131 | 176 | 656 | 735 |
| Total Common Shares Outstanding |